| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K24690302 |
| PharmacoGx | BRD-K24690302 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZNF322 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | DDC | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | UMOD | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | PROX1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | IDH2 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | EIF4EBP2 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | NKAIN2 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | CNNM3 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | CACFD1 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | TAS2R9 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
